A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

NCT02730689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: DP-R207
DRUG: Rosuvastatin
DRUG: Ezetimibe

Sponsor

Alvogen Korea